Ceftriaxone for Typhoid Fever
For typhoid fever, use IV ceftriaxone 80 mg/kg once daily (maximum 4 grams) for 5-7 days in children, and 2-4 grams once daily for 7 days in adults. This represents the WHO-recommended second-line therapy when fluoroquinolones cannot be used due to resistance or contraindications 1.
Dosing Recommendations
Children
- Dose: 80 mg/kg IV once daily
- Maximum: 4 grams per day
- Duration: 5-7 days 1
- Administration: Infuse over 30 minutes (60 minutes in neonates) 2
Adults
- Dose: 2-4 grams IV once daily
- Duration: 7 days
- Maximum: 4 grams per day 2
Evidence Quality and Nuances
The WHO Pocket Book guidelines 1 position ceftriaxone as second-line therapy after ciprofloxacin (15 mg/kg twice daily for 7-10 days), with azithromycin as an alternative. This hierarchy reflects the reality of fluoroquinolone resistance patterns, particularly in South Asia.
Clinical trial data reveals important caveats:
Shorter courses (3-5 days) show mixed results: While some studies demonstrated 79-95% cure rates with 3-5 day regimens 3, 4, a critical pediatric trial in Pakistan found 14% relapse rates with 7-day treatment versus 0% with 14-day treatment for multidrug-resistant typhoid 5. This suggests 7 days is the minimum safe duration.
Fever clearance is slower with ceftriaxone: Compared to fluoroquinolones, ceftriaxone causes defervescence 1.7 days later on average 6, and some patients remain febrile for 9-13 days despite successful treatment 3. This prolonged fever does not indicate treatment failure - continue the full course unless complications develop.
Microbiological clearance is superior: Blood cultures become negative faster with ceftriaxone than chloramphenicol (0% vs 60% positive on day 3) 3, indicating excellent bactericidal activity despite slower clinical response.
When to Choose Ceftriaxone
Use ceftriaxone as first-line when:
- Fluoroquinolone resistance is documented or suspected (common in South Asia)
- Patient is pregnant (fluoroquinolones contraindicated)
- Child under 8 years (avoid fluoroquinolones)
- Extensively drug-resistant (XDR) typhoid suspected
Consider alternatives when:
- Azithromycin may be preferable for uncomplicated cases in children (91-97% cure rates, oral administration) 7
- Fluoroquinolones remain effective if local susceptibility confirmed
- Cephalosporin resistance documented (emerging problem) 8
Critical Pitfalls
Don't stop at 3-5 days: Despite older studies suggesting shorter courses work, the relapse data in children mandates 7-day minimum 5
Don't interpret prolonged fever as failure: Up to 11 days of fever can occur with successful treatment 6, 3. Reassess only if fever persists beyond 2 weeks or new complications arise.
Avoid calcium-containing solutions: Ceftriaxone precipitates with calcium - never mix with Ringer's lactate or give calcium infusions concurrently, especially in neonates 2
Monitor for relapse: 4-14% relapse rate reported even with adequate treatment 4, 5. Follow patients for 4 weeks post-treatment.
Check local resistance patterns: Cephalosporin resistance is emerging 8. If no clinical improvement by day 5-7, obtain repeat cultures and consider meropenem or azithromycin.
Comparative Performance
A 2022 Cochrane review 9 found low-certainty evidence that ceftriaxone may reduce clinical failure compared to azithromycin (RR 0.42), but the evidence base consists primarily of small, older trials. Ceftriaxone remains highly effective with minimal adverse effects, making it a reliable choice when fluoroquinolones cannot be used, though azithromycin offers the advantage of oral administration for uncomplicated cases.
The FDA label 2 confirms standard adult dosing of 1-2 grams daily, though WHO guidelines and clinical trials support higher doses (2-4 grams) for serious infections like typhoid.